Landmark Financial Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $958K | Hold |
6,181
| – | – | 0.34% | 39 |
|
|
2023
Q3 | $921K | Hold |
6,181
| – | – | 0.37% | 39 |
|
|
2023
Q2 | $833K | Sell |
6,181
-250
| -4% | -$36.7K | 0.34% | 42 |
|
|
2023
Q1 | $1.02M | Sell |
6,431
-28
| -0.4% | -$4.28K | 0.45% | 39 |
|
|
2022
Q4 | $1.04M | Sell |
6,459
-250
| -4% | -$38.3K | 0.48% | 34 |
|
|
2022
Q3 | $900K | Sell |
6,709
-1
| -0% | -$143 | 0.48% | 34 |
|
|
2022
Q2 | $1.03M | Sell |
6,710
-241
| -3% | -$36.8K | 0.51% | 29 |
|
|
2022
Q1 | $1.09M | Buy |
6,951
+241
| +4% | +$35K | 0.52% | 28 |
|
|
2021
Q4 | $909K | Buy |
6,710
+67
| +1% | +$7.91K | 0.4% | 36 |
|
|
2021
Q3 | $719K | Sell |
6,643
-147
| -2% | -$16.8K | 0.39% | 34 |
|
|
2021
Q2 | $765K | Buy |
6,790
+147
| +2% | +$16.6K | 0.37% | 35 |
|
|
2021
Q1 | $719K | Hold |
6,643
| – | – | 0.39% | 34 |
|
|
2020
Q4 | $724K | Buy |
6,643
+509
| +8% | +$48.9K | 0.41% | 34 |
|
|
2020
Q3 | $539K | Sell |
6,134
-187
| -3% | -$17.6K | 0.34% | 38 |
|
|
2020
Q2 | $626K | Buy |
6,321
+27
| +0.4% | +$2.38K | 0.41% | 33 |
|
|
2020
Q1 | $517K | Sell |
6,294
-41
| -0.6% | -$3.49K | 0.35% | 35 |
|
|
2019
Q4 | $540K | Hold |
6,335
| – | – | 0.31% | 35 |
|
|
2019
Q3 | $479K | Hold |
6,335
| – | – | 0.3% | 35 |
|
|
2019
Q2 | $460K | Buy |
6,335
+5
| +0.1% | +$393 | 0.28% | 34 |
|
|
2019
Q1 | $510K | Buy |
6,330
+5
| +0.1% | +$409 | 0.33% | 34 |
|
|
2018
Q4 | $583K | Buy |
6,325
+3
| +0% | +$264 | 0.38% | 33 |
|
|
2018
Q3 | $597K | Buy |
6,322
+3
| +0% | +$284 | 0.36% | 33 |
|
|
2018
Q2 | $585K | Buy |
6,319
+86
| +1% | +$8.4K | 0.36% | 31 |
|
|
2018
Q1 | $590K | Buy |
6,233
+2
| +0% | +$220 | 0.37% | 31 |
|
|
2017
Q4 | $602K | Buy |
6,231
+2
| +0% | +$188 | 0.38% | 31 |
|
|
2017
Q3 | $554K | Buy |
6,229
+3
| +0% | +$228 | 0.37% | 30 |
|
|
2017
Q2 | $451K | Buy |
6,226
+3
| +0% | +$202 | 0.32% | 35 |
|
|
2017
Q1 | $406K | Buy |
6,223
+3
| +0% | +$189 | 0.3% | 35 |
|
|
2016
Q4 | $390K | Buy |
6,220
+83
| +1% | +$5.07K | 0.31% | 36 |
|
|
2016
Q3 | $387K | Buy |
6,137
+403
| +7% | +$26.1K | 0.33% | 36 |
|
|
2016
Q2 | $355K | Buy |
5,734
+3
| +0.1% | +$183 | 0.33% | 40 |
|
|
2016
Q1 | $327K | Buy |
5,731
+203
| +4% | +$11.3K | 0.33% | 39 |
|
|
2015
Q4 | $327K | Buy |
5,528
+2
| +0% | +$115 | 0.34% | 35 |
|
|
2015
Q3 | $300K | Buy |
5,526
+3
| +0.1% | +$195 | 0.33% | 32 |
|
|
2015
Q2 | $371K | Buy |
5,523
+2
| +0% | +$131 | 0.38% | 33 |
|
|
2015
Q1 | $323K | Buy |
5,521
+169
| +3% | +$10.2K | 0.34% | 35 |
|
|
2014
Q4 | $355K | Buy |
+5,352
| New | +$337K | 0.37% | 34 |
|
Other funds holding ABBV
